Nothing gets an intellectual’s blood pumping quite like a rapid-fire
quiz or seminar, something that really speeds up those brainy juices.
The first two days of the 36th Asia-Pacific Academy of Ophthalmology Virtual Congress (APAO 2021)
have certainly provided us with plenty of symposiums at a blistering pace.
One of the foremost when it comes to relentless energy was Rapid Fire Retina 2 (Medical – other)
Update Session, which went live on Monday, September 6 ลาวสามัคคี วีไอพี.
Chaired by Dr. Prof. Xinyuan Zhang, PhD, professor and supervisor at the Beijing Institute of Ophthalmology,
Beijing TongRen Eye Center in China, the session covered a number of current issues in the retina field.
Moving from a case study report on the use of The Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular Age-Related Macular Degeneration
(nAMD): Data Update and Key Surgical Pearls, to a report on the penetration of topical levofloxacin, and the presence of lipoprotein
A as a risk factor for polypoidal choroidal vasculopathy
and AMD, this is one symposium you should return to view again.
Indeed, the first presentation about ranibizumab for nAMD really lived up to the name of the symposium
and was delivered in blistering fashion by A/Prof. Andrew Chang, a clinical associate professor at the University of Sydney, Australia.
He reported on a trial involving a port delivery system with ranibizumab, a permanent refillable ocular implant customized for the drug.
Patients were observed over a 96-day period and less than 10% required additional treatment before each refill.
A/Prof. Chang stated that the change in best corrected visual acuity remained non-inferior through two refills after 44 weeks.
Pointing to less than 10% requiring further treatment, he said the safety profile is “well categorized and manageable”.
He concluded that the use of this delivery system is of benefit to patients, provided that optimized implant insertion procedures are maintained. While we absolutely enjoyed his presentation, perhaps
Dr. Sadik Etka Bayramoglu, an ophthalmologist at the Kanuni Sultan Süleyman Training
and Research Hospital Istanbul, Turkey, didn’t get the memo about rapid-fire style.
For more information: ลาวสามัคคี วีไอพี